期刊
CLINICAL AND EXPERIMENTAL ALLERGY
卷 45, 期 1, 页码 220-231出版社
WILEY
DOI: 10.1111/cea.12449
关键词
25(OH)D3; allergens; allergic disease; cord blood; cytokines; eczema; Toll-like receptor; Vitamin D
资金
- National Health and Medical Research Council (NHMRC) of Australia [458502]
- NHMRC
BackgroundVitamin D (25[OH]D3) status in early life has been linked to the risk of allergic disease in multiple observational studies. While immunomodulating properties are well recognized, there are few longitudinal studies of 25(OH)D3 status, immune function and allergic disease in infants. ObjectiveTo investigate 25(OH)D3 levels at birth [cord blood (CB)] and at 6months of age in relation to immune function at 6months of age, and clinical outcomes up to 30months of age in infants with a maternal history of atopy. MethodsIn a subset of infants (n=225) enrolled in a RCT (ACTRN12606000281594), 25(OH)D3 levels were assessed in relation to peripheral blood mononuclear cell cytokine responses to house dust mite (HDM), ovalbumin (OVA) and -lactoglobulin allergens, or Toll-like receptor (TLR) ligands (lipopolysaccharide, lipoteichoic acid, polyinosinic:polycytidylic acid and CpG oligonucleotide) at 6months of age, in addition to clinical outcomes (eczema, wheeze and allergen sensitisation) up to 30months of age. ResultsInfants with higher 25(OH)D3 at birth (75nmol/L, compared with <50nmol/L) had lower IL-5 and IL-13 responses to HDM by 6months (P<0.001 and P=0.003, respectively). This was also reflected in strong inverse correlations between CB 25(OH)D3 levels and HDM IL-13 (=-0.57; P=0.0002) and IL-5 (=-0.59, P=0.0001) responses, with a similar trend for IL-5 (=-0.29; P=0.009) responses to OVA. For innate stimulations, higher 25(OH)D3 levels at 6months were associated with greater responses to TLR ligands. Additionally, higher CB 25(OH)D3 was associated with reduced risk eczema at 6months (P=0.011) and 12months (P=0.034). ConclusionThis suggests that improving 25(OH)D3 status in pregnancy or early infancy may reduce the development of allergic disease in high-risk infants by inhibiting cytokine profiles associated with allergy. Results of clinical trials are awaited to determine the efficacy of vitamin D supplementation in allergy prevention.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据